Stay updated on Durvalumab Combo in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Lung Cancer Clinical Trial page.

Latest updates to the Durvalumab Combo in Lung Cancer Clinical Trial page
- Check2 days agoChange DetectedAdded Revision: v3.5.3 and removed Revision: v3.5.2, reflecting a minor platform update to the page's version label.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed. This is a minor labeling update to the page's metadata.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check45 days agoChange DetectedRevision: v3.5.0 was added to the record history and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check52 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the version history.SummaryDifference0.1%

- Check80 days agoChange DetectedA new Study Status entry was added on 2026-02-10 and the version history shows 32 with Revision: v3.4.2. The page also removes a government funding operating status notice from the previous version.SummaryDifference0.8%

- Check87 days agoChange DetectedAdded a Notice about government funding lapse and the NIH facilities' operating status. Updated the page Revision from v3.4.0 to v3.4.1.SummaryDifference0.6%

Stay in the know with updates to Durvalumab Combo in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Lung Cancer Clinical Trial page.